Gene · 2050
Papers2,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Angiogenic regulation of dental pulp stem cells. | Front Dent Med | 2025 | 41458173 | PubTator, text mining | PubMed |
| Capillary malformation-arteriovenous malformation syndrome (CM-AVM): a systematic review of cerebrovascular manifestations. | Childs Nerv Syst | 2025 | 41398316 | PubTator, text mining | PubMed |
| Insulin use promotes pro-inflammatory changes in the transcriptome of atherosclerotic plaques in patients with diabetes mellitus. | J Mol Cell Cardiol Plus | 2025 | 41377472 | PubTator, text mining | PubMed |
| The "double-edged sword" effect of non-steroidal anti-inflammatory drugs (NSAIDs) in the treatment of endometriosis (EMS). | Reprod Biol Endocrinol | 2025 | 41353125 | PubTator, text mining | PubMed |
| Fracture healing: cellular mechanisms and impact of parathyroid hormone and its analogs. | Front Endocrinol (Lausanne) | 2025 | 41334438 | PubTator, text mining | PubMed |
| Employing plasma proteins in proteomic Mendelian randomization analysis to identify therapeutic targets for duodenal ulcer. | Medicine (Baltimore) | 2025 | 41261599 | PubTator, text mining | PubMed |
| EphrinB2 in dental pulp stem cells promotes endothelial cells forming capillary-like cords in a 3D bioprinted hydrogel construct. | BMC Mol Cell Biol | 2025 | 41162886 | PubTator, text mining | PubMed |
| Hypoxia-driven circ-TBC1D1/miR-520h/EPHB4 impairs trophoblast function in unexplained recurrent spontaneous abortion. | Sci Rep | 2025 | 41087455 | PubTator, text mining | PubMed |
| Identification of novel high-risk genes in gastric cancer through single-cell RNA sequencing, eQTL Mendelian randomization, and in vitro validation. | Glob Med Genet | 2025 | 41050213 | PubTator, text mining | PubMed |
| Design and Evaluation of Eb4Mab-7-mG2a: A Dual-Action Anti-EphB4 Monoclonal Antibody for Targeted Breast Cancer Therapy. | Cancer Sci | 2025 | 41023731 | PubTator, text mining | PubMed |
| Single-vessel transcriptome map pathological landscapes and reveal NR2F2-mediated smooth muscle cell phenotype acquisition in capillary malformations. | bioRxiv | 2025 | 40950147 | PubTator, text mining | PubMed |
| Micropuncture and granular hydrogel scaffolds to surgically bioengineer a perfusable and stably patterned microvasculature. | Angiogenesis | 2025 | 40928571 | PubTator, text mining | PubMed |
| The Role of EphrinB2-EphB4 Signalling Pathway in Regeneration of Inflammatory Bone Defect. | J Cell Mol Med | 2025 | 40913251 | PubTator, text mining | PubMed |
| Trial in progress: phase I study of non-viral gene-modified CAR-T cell therapy for malignant solid tumors expressing EPHB4 receptor (CARTiEr). | Front Oncol | 2025 | 40842575 | PubTator, text mining | PubMed |
| Unveiling the protein landscape for early detection of colorectal precancerous lesions. | Clin Proteomics | 2025 | 40841878 | PubTator, text mining | PubMed |
| LYMTACs:chimeric small molecules repurpose lysosomal membrane proteins for target protein relocalization and degradation. | Nat Commun | 2025 | 40841368 | PubTator, text mining | PubMed |
| Coronary microvascular disease in heart failure with preserved ejection fraction. | Physiol Rep | 2025 | 40834289 | PubTator, text mining | PubMed |
| Identification of Common Cancer Antigens Useful for Specific Immunotherapies to Colorectal Cancer and Liver Metastases. | Int J Mol Sci | 2025 | 40806530 | PubTator, text mining | PubMed |
| Tissue microarray and liquid biopsy approaches identify EphB3, cMet, and miR-3168 as biomarkers of colorectal cancer. | Cell Cycle | 2025 | 40790791 | PubTator, text mining | PubMed |
| Trametinib treatment for early-stage extracranial arteriovenous malformations: A multicenter, prospective, single-arm pilot study. | J Am Acad Dermatol | 2025 | 40683355 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2050/papers?page=4